ArticleClinics (Sao Paulo, Brazil)2026
Diagnosis of myocardial infarction in early presenters using 1-hour delta of high sensitive Troponin I: a pilot study.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe accurate and timely diagnosis of Non-ST Elevation Myocardial Infarction (NSTEMI) in early presenter is important to reduce false negative cases. We aimed to discern the diagnostic cut-off of high-sensitive cardiac Troponin I (hs-cTnI) in early presenters who lack preexisting cardiac morbidity.
methodThis is a record-based study in which we included data from 457 patients who presented to emergency care with symptoms suggestive of suspected Acute Coronary Syndrome (ACS). We calculated sensitivity and Negative Predictive Value (NPV) for rule out and specificity and Positive Predictive Value (PPV) to rule in NSTEMI at various cut-off levels of hs-cTnI. In addition, we used binary logistic regression to identify the best predictor for NSTEMI diagnosis.
resultWe observed 91% sensitivity and 79% NPV at a baseline hs-cTnI level below 2 ng/L. However, this was insufficient to rule out NSTEMI. In addition, we found 1-hour delta (absolute delta) hs-cTnI to be the best predictor of NSTEMI. To rule in NSTEMI, specificity was 95%, and PPV was 77% at 4 ng/L 1-hour delta hs-cTnI. The Area Under Curve (AUC) in the Receiver Operating Characteristic (ROC) was 0.796 (p-value = 0.001) for 1-hour delta hs-cTnI.
conclusionIn early presenters without prior heart disease, a single baseline hs-cTnI measurement below 3 ng/L provided 86% NPV, but this was insufficient for safe rule-out, confirming that serial sampling is necessary. Standard 99th percentile cut-offs performed poorly in this population. Incorporation of a 1-hour delta assessment improved diagnostic discrimination. Further, even a low 1-hour delta hs-cTnI (4 ng/L) can rule in NSTEMI. However, due to nature of this pilot study, our 4 ng/L rule-in criterion needs to be validated in further studies before being used in the clinics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.